Australia Periodontal Disease Treatment Market (2024-2029)
The Australia Periodontal Disease Treatment Market was valued at $17.35 Million in 2024 and projected to reach to $23.97 Million by 2029, representing a compound annual growth rate of 5.5%. Australia's periodontal disease treatment market is positioned for consistent growth through 2029, supported by an aging population with higher disease prevalence and increasing consumer awareness of oral health importance.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Australia Periodontal Disease Treatment Market Trends and Insights
- Australia's aging population and rising awareness of oral health are driving demand for advanced periodontal therapies, including non-surgical and surgical interventions.
- The market in Australia is supported by strong healthcare infrastructure, increasing dental insurance coverage, and growing adoption of minimally invasive treatment technologies. In Australia, the periodontal treatment landscape is evolving with greater emphasis on preventive care and early intervention strategies.
- Australia's dental professionals are increasingly integrating digital diagnostics and laser-assisted procedures to improve patient outcomes.
- The forecast period through 2029 indicates sustained growth in Australia as healthcare expenditure on specialized dental services continues to rise, supported by both public and private sector investments in oral health infrastructure..
Key Market Statistics
- CAGR (2024-2029) 5.5% CAGR
- Market Size, 2024 ~USD 17.35 Million
- Forecast, 2029 ~USD 23.97 Million
- Country Australia
Australia Periodontal Disease Treatment Market Overview
Market Valuation :
Australia's periodontal disease treatment market reached USD 17.35 million in 2024, with projected growth to USD 23.97 million by 2029, representing a steady 5.5% CAGR.
Aging Population Driver :
Australia's rapidly aging demographic is significantly increasing the prevalence of periodontal disease, creating sustained demand for both preventive and therapeutic treatment options.
Advanced Treatment Adoption :
Australian dental practitioners are increasingly adopting non-surgical and surgical periodontal interventions, driven by rising patient awareness and improved access to innovative therapies.
Healthcare Infrastructure :
Australia's well-developed healthcare system and strong dental care standards support market expansion through private practice growth and public health initiatives focused on oral health.
Australia Periodontal Disease Treatment Market Dynamics
- The market benefits from Australia's advanced healthcare infrastructure, rising disposable incomes, and growing adoption of minimally invasive treatment technologies.
- Private dental practices are expanding service offerings in periodontal care, while public health campaigns continue to emphasize preventive measures.
- The 5.5% CAGR reflects steady demand for both established and emerging treatment modalities, with particular growth in non-surgical therapies and digital diagnostic tools..
Related Ecosystem
Dental Devices
- Dental Implants
- Dental Bone Grafts
- Dental Crowns
- Dental Prosthetics
- Zirconium Implants
- DENTSPLY SIRONA Inc.
- Henry Schein, Inc.
- KAVO KERR GROUP
- PLANMECA GROUP
- Patterson Companies, Inc.
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- Australia's periodontal disease treatment market is valued at USD 17.35 million in 2024 and will reach USD 23.97 million by 2029.
- Australia experiences a 5.5% CAGR, driven by aging demographics and increased oral health awareness.
- Australia's market benefits from advanced healthcare infrastructure and rising adoption of minimally invasive technologies.
- Australia's periodontal sector is shifting toward preventive care and digital diagnostic integration through 2029.
Periodontal Disease Treatment Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | AGGRESSIVE PERIODONTITIS (Disease) |
| Forecast Period | 2024–2029 |
| Growth Rate | CAGR of 5.9% from 2024 to 2029 |
| Largest Segment | NON-SURGICAL TREATMENT (Treatment) |
| Market Size Base Year (Billions) | ~USD 2.57 (2024) |
| Revenue Forecast (Billions) | ~USD 3.43 (2029) |
| Segments Covered | Product, Disease, Type, Treatment |
Australia Periodontal Disease Treatment Market Report Segmentation
4 segment dimensions are covered across the global market.
By Product
- Consumables
- Equipment
- Medication
By Disease
- Aggressive Periodontitis
- Chronic Periodontitis
- Gingivitis
- Other Diseases
By Type
- Acute Gingivitis
- Chronic Gingivitis
- Medication Therapy
- Recurrent Gingivitis
- Root Planing
- Scaling
By Treatment
- Bone Grafting
- Flap Surgery/Pocket Reduction Therapy
- Guided Tissue Regeneration
- Non-Surgical Treatment
- Other Treatments
- Soft Tissue Graft
Target Audience
- Dental Device Manufacturers : Need Australia-specific market data to assess market entry opportunities, competitive positioning, and demand forecasts for periodontal treatment devices and instruments.
- Pharmaceutical Companies : Require detailed insights into periodontal drug therapy adoption rates and treatment preferences in Australia to guide product development and commercialization strategies.
- Private Dental Practice Owners : Seek market intelligence on periodontal service demand, patient demographics, and growth trends in Australia to optimize service offerings and business expansion plans.
- Healthcare Investors & PE Firms : Need comprehensive market analysis and growth projections for Australia's periodontal sector to evaluate investment opportunities and portfolio company valuations.
- Healthcare Consultants & Advisors : Require country-specific market data and forecasts to provide evidence-based recommendations to clients operating in or entering Australia's dental and periodontal treatment market.
Key Companies in the Australia Periodontal Disease Treatment Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| DENTSPLY SIRONA | United States | Public Company | Connected Technology Solutions,Essential Dental Solutions,Orthodontic and Implant Solutions, |
| ENVISTA HOLDINGS CORPORATION | United States | Public Company | Specialty Products & Technologies – Implants & Biomaterials,Specialty Products & Technologies – Orthodontics & Clear Aligners,Equipment & Consumables – Imaging, Software & Visualization, |
| HENRY SCHEIN, INC. | United States | Public Company | Global Distribution and Value-Added Services,Global Specialty Products,Global Technology, |
| BIOLASE, INC. | United States | Public Company | Waterlase all-tissue systems,Diode soft-tissue systems,Consumables, fibers, and handpieces, |
| NAKANISHI INC. | Japan | Public Company | Dental handpieces (air turbines, contra-angles, micromotors),Surgical and mobile dentistry systems,Dental lab, hygiene, and maintenance products, |
| A-DEC INC. | Switzerland | Public Company | Flexible placement (temporary staffing and contracting),Permanent placement and career transition,Outsourcing and engineering consulting, |
DENTSPLY SIRONA
DENTSPLY SIRONA is a United States-based public company founded in 1877 with 14,000 employees. The company operates in the dental industry.
ENVISTA HOLDINGS CORPORATION
ENVISTA HOLDINGS CORPORATION is a United States-based public company founded in 2018 with 12,000 employees. The company operates in the dental industry.
HENRY SCHEIN, INC.
HENRY SCHEIN, INC. is a United States-based public company founded in 1932 with 25,000 employees. The company operates in the dental industry.
BIOLASE, INC.
BIOLASE, INC. is a United States-based public company founded in 1984 with 157 employees. The company operates in the dental industry.
NAKANISHI INC.
NAKANISHI INC. is a Japan-based public company founded in 1930 with 2,204 employees. The company operates in the dental industry.
A-DEC INC.
A-DEC INC. is a Switzerland-based public company founded in 1957 with 33,569 employees. The company operates in the dental industry.
Reasons to Buy this Report
- Market Size & Growth Validation : Obtain precise valuation data for Australia's periodontal market (USD 17.35M in 2024) with verified 5.5% CAGR projections through 2029 to support investment and expansion decisions.
- Demographic Insights : Access detailed analysis of Australia's aging population trends and their direct correlation to periodontal disease prevalence, enabling targeted market positioning and service development.
- Treatment Modality Analysis : Understand the competitive landscape of non-surgical and surgical periodontal interventions specific to Australia, including adoption rates and practitioner preferences for strategic planning.
- Regional Market Dynamics : Gain country-specific insights into Australia's healthcare infrastructure, regulatory environment, and private vs. public sector dynamics that influence market opportunities and barriers.
- Competitive Positioning : Benchmark your offerings against market trends in Australia, identify growth segments, and develop localized strategies to capture market share in this high-value developed market.
Frequently asked questions
What is the current size of Australia's periodontal disease treatment market?
Australia's periodontal disease treatment market was valued at USD 17.35 million in 2024.
What is the projected market size for Australia by 2029?
Australia's periodontal disease treatment market is forecast to reach USD 23.97 million by 2029.
What is the CAGR for Australia's periodontal treatment market?
Australia's periodontal disease treatment market is expected to grow at a compound annual growth rate of 5.5% from 2024 to 2029.
What factors are driving growth in Australia's periodontal market?
Growth in Australia is driven by an aging population, rising oral health awareness, strong healthcare infrastructure, and increasing adoption of minimally invasive treatment technologies.
What treatment trends are emerging in Australia's periodontal sector?
Australia's periodontal sector is increasingly adopting digital diagnostics, laser-assisted procedures, and preventive care strategies to improve patient outcomes.
RESEARCH METHODOLOGY
Get the Full Periodontal Disease Treatment Market Report
Full forecast, segment splits, and company analysis for all Periodontal Disease Treatment Market.
- US Periodontal Disease Treatment Market
- Canada Periodontal Disease Treatment Market
- Germany Periodontal Disease Treatment Market
- France Periodontal Disease Treatment Market
- UK Periodontal Disease Treatment Market
- Italy Periodontal Disease Treatment Market
- Spain Periodontal Disease Treatment Market
- China Periodontal Disease Treatment Market
- Japan Periodontal Disease Treatment Market
- India Periodontal Disease Treatment Market
- South Korea Periodontal Disease Treatment Market
- Mexico Periodontal Disease Treatment Market
- Brazil Periodontal Disease Treatment Market
- Argentina Periodontal Disease Treatment Market
- Rest Of Asia Pacific Periodontal Disease Treatment Market
- Rest Of Europe Periodontal Disease Treatment Market
- Rest Of Latin America Periodontal Disease Treatment Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report